Important Information:read This First - i-SENS CareSens N Pop Owner's Booklet

Important Information:Read This First!

To receive safe and optimum system benefits, please read the
entire manual contents before using the system. Please note the
following instructions:
Intended use:
CareSens N POP Blood Glucose Monitoring System is used for
the quantitative measurement of the glucose level in capillary
whole blood as an aid in monitoring diabetes management
effectively at home or in clinical settings. CareSens N POP
Blood Glucose Monitoring System should be used only for
self-testing outside the body (in vitro diagnostic use only).
CareSens N POP Blood Glucose Monitoring System should not
be used for the diagnosis of diabetes or for testing newborns.
Testing sites include the traditional fingertip testing along
with alternate sites testing on forearm, palm, thigh and calf.
The following chart explains the symbols you'll find in the
CareSens N POP owner's booklet, product packaging, and
product inserts.
For in vitro diagnostic use
This product fulfills the requirements for Directive 98/79/EC
on in vitro diagnostic medical devices
Cautions for safety and optimum product use
Use by (unopened or opened test strip vial)
Do not discard this product with other household-type
waste
Do not reuse
Consult instruction for use
Temperature limitations
4 www.i-sens.com
Authorised representative
Batch code
Manufacturer
Serial number
Important Information
• T he CareSens N POP Blood Glucose Monitoring System is
intended for self-testing outside the body (in vitro diagnostic
use).
• G lucose in blood samples reacts with the chemical in the
test strip to produce a small electrical current.
• T he CareSens N POP Blood Glucose Meter is designed to
minimize code related errors in monitoring by using the
no-coding function.
• T he CareSens N POP Blood Glucose Meter should be used
only with the CareSens N Test Strips.
• A n abnormally high or low red blood cell count (haematocrit
level over 65% or below 15%) may produce inaccurate
results.
• I f your test result is below 3.3 mmol/L or above 13.3 mmol/L,
consult a healthcare professional immediately.
• A lternative site and fingertip test results may differ
significantly due to rapid change in the blood glucose level
after meal, insulin injection, or exercise.
• I naccurate results may occur in severely hypotensive
individuals or patients in shock. Inaccurate low results
may occur for individuals experiencing a hyperglycaemic-
hyperosmolar state, with or without ketosis. Critically ill
patients should not be tested with blood glucose meters.
• I naccurate results may occur in patients undergoing
oxygen therapy.
If you need assistance, please contact the Spirit Healthcare 24/7
Freephone Support Line at 0800 881 5423 or go to www.spirit-
healthcare.co.uk.
www.spirit-healthcare.co.uk 5